When it comes to cataracts, many Americans are torn about what to do when they are faced with this health challenge. Although a lot of cataract patients simply opt for the surgery, there is always a chance that there could be complications.
In fact, some people never recover their eyesight properly after going through cataract surgery. For those who are concerned about having to deal with this, however, it seems as though help may be on the horizon.
A steroid known as lanosterol, which occurs naturally, is now being tested as a viable treatment option for people who suffer from cataracts. After observing two children in China who were afflicted with cataracts, scientists were able to determine that lanosterol can affect the presentation of cataracts.
Using donated human lenses from cadavers, a research team was recently able to discover that lanosterol had the capacity to shrink cataracts. By stopping the proteins that cause cataracts in their tracks, this steroid is believed to be highly effective.
Although the lanosterol drops are still in the testing phase, many people in the medical community are excited to see them become available on the market.
The good news is that the research community is heralding the studies as very significant, indicating that they believe the drops have an excellent chance of making it to the market and helping patients to see more clearly.
